Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Entamoeba histolytica | hypothetical protein | 0.0036 | 0.0347 | 0.5 |
Trichomonas vaginalis | set domain proteins, putative | 0.0234 | 1 | 0.5 |
Brugia malayi | bZIP transcription factor family protein | 0.0083 | 0.2653 | 0.3036 |
Schistosoma mansoni | hypothetical protein | 0.0036 | 0.0347 | 0.1596 |
Echinococcus granulosus | Basic leucine zipper bZIP transcription factor | 0.0083 | 0.2653 | 1 |
Entamoeba histolytica | hypothetical protein | 0.0036 | 0.0347 | 0.5 |
Echinococcus granulosus | Basic leucine zipper bZIP transcription | 0.0036 | 0.0347 | 0.1308 |
Echinococcus granulosus | jun protein | 0.0083 | 0.2653 | 1 |
Brugia malayi | Pre-SET motif family protein | 0.0206 | 0.8618 | 1 |
Schistosoma mansoni | transcription factor LCR-F1 | 0.0036 | 0.0347 | 0.1596 |
Entamoeba histolytica | hypothetical protein | 0.0036 | 0.0347 | 0.5 |
Brugia malayi | hypothetical protein | 0.0036 | 0.0347 | 0.0344 |
Loa Loa (eye worm) | hypothetical protein | 0.0081 | 0.2543 | 0.2907 |
Echinococcus multilocularis | Basic leucine zipper (bZIP) transcription factor | 0.0083 | 0.2653 | 1 |
Echinococcus multilocularis | Basic leucine zipper (bZIP) transcription | 0.0036 | 0.0347 | 0.1132 |
Loa Loa (eye worm) | pre-SET domain-containing protein family protein | 0.0206 | 0.8618 | 1 |
Toxoplasma gondii | histone lysine methyltransferase SET/SUV39 | 0.003 | 0.0053 | 0.5 |
Schistosoma mansoni | jun-related protein | 0.0068 | 0.1898 | 1 |
Onchocerca volvulus | 0.0065 | 0.1787 | 0.1743 | |
Echinococcus granulosus | histone lysine methyltransferase setb | 0.003 | 0.0053 | 0.0199 |
Echinococcus multilocularis | jun protein | 0.0083 | 0.2653 | 1 |
Brugia malayi | hypothetical protein | 0.0065 | 0.1787 | 0.2025 |
Schistosoma mansoni | hypothetical protein | 0.0068 | 0.1898 | 1 |
Plasmodium vivax | SET domain protein, putative | 0.003 | 0.0053 | 0.5 |
Entamoeba histolytica | hypothetical protein | 0.0036 | 0.0347 | 0.5 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.